Download Mucosal Drug Delivery Systems: A Comprehensive Overview and more Assignments Pharmacy in PDF only on Docsity!
Mawlana Bhashani Science and Technology University
Santosh, Tangail-1902.
Assignment on: Mucosal drug delivery system.
Department of Pharmacy.
Course title: Advanced Drug Delivery and Nanotechnology.
Course code: PHAR- 6107.
Part 1 Submitted by Name: Syed Salauddin Parvez Student ID: PHA- 16033 Part 2 Submitted by Name: Nazmul Mahmud Student ID: PHA- 16024 Submitted to Dr. Md. Ashraf Ali Associate Professor Department of Pharmacy Faculty of Life Science Mawlana Bhashani Science & Technology University, Santosh, Tangail- 1902 , Bangladesh.
Contents
Part- 1
1. Introduction
Mucosal drug delivery system is a novel and promising approach to drug delivery that involves the administration of drugs through the mucosal surfaces of the body. Mucosal surfaces are present in various organs such as the oral cavity, nasal cavity, pulmonary system, gastrointestinal tract, rectum, and vagina. These surfaces are highly vascularized, have a large surface area, and offer a rapid onset of drug action due to the presence of numerous blood vessels and lymphatic vessels. The primary goal of mucosal drug delivery is to enhance drug absorption and bioavailability, decrease systemic side effects, and increase patient compliance. Mucosal drug delivery systems offer several advantages over traditional drug delivery methods such as oral and parenteral routes. These advantages include improved drug delivery, enhanced bioavailability, reduced first-pass metabolism, and fewer side effects. The anatomy and physiology of the mucosal surfaces play a crucial role in drug absorption and bioavailability. The mucosal surfaces are lined with a layer of mucus, which acts as a natural barrier to drug absorption. The mechanism of mucoadhesion, which involves the binding of the drug to the mucosal surface, helps to overcome this barrier and promote drug absorption. Several theories of mucoadhesion have been proposed, including electrostatic attraction, hydrogen bonding, and van der Waals forces. The choice of the mucoadhesive polymer and the site of administration is critical to the success of mucosal drug delivery (Laffleur & Bernkop-Schnürch, 2013). In this assignment, we will discuss about anatomy and physiology of oral mucosa. We will also talk through mucoadhesion and the different types of theories of mucoadhesion. Then, we will explore the different sites of mucosal drug delivery, including the oral cavity, buccal, nasal, pulmonary, gastrointestinal tract, rectal, and vaginal drug delivery systems. Finally, we will discuss the future directions and innovations of mucosal drug delivery in various areas.
2. Anatomy and Physiology of Oral Mucosa
The oral mucosa is the moist membrane that lines the inside of the mouth, including the cheeks, lips, tongue, gums, hard palate and soft palate. It is a complex structure composed of multiple
layers of specialized cells, connective tissues, blood vessels, and nerves. The anatomy and physiology of oral mucosa plays an important role in the design and optimization of drug delivery systems. 2.1 Structure of the oral mucosa: The oral mucosa is composed of three layers: ❑ Epithelium: The epithelium is the outermost layer of the oral mucosa. It is a stratified squamous epithelium, which consists of several layers of flattened cells. The epithelium is responsible for protecting the underlying tissues from physical and chemical damage, as well as regulating the exchange of fluids and gases. Figure 1 : Structure of the oral mucosa (Sapna et al., 2017). ❑ Lamina propria: The lamina propria is the middle layer of the oral mucosa. It is composed of loose connective tissue, which contains blood vessels, lymphatic vessels, and nerves. The lamina propria provides structural support and nutrition to the epithelium, as well as contributing to the immune response. ❑ Submucosa: The submucosa is the deepest layer of the oral mucosa. It is composed of dense connective tissue, which contains larger blood vessels, nerves, and salivary glands. The submucosa provides additional support and nutrition to the oral mucosa, as well as contributing to the regulation of salivary secretion (Sapna et al., 2017).
3. Mucoadhesion
Mucoadhesion is the process by which a drug delivery system adheres to the mucosal surface, such as the oral mucosa, nasal mucosa, gastrointestinal mucosa, or vaginal mucosa. This type of drug delivery system has gained significant interest in the pharmaceutical industry due to its ability to enhance drug absorption and improve bioavailability. The mechanism of mucoadhesion involves several factors that affect the adhesion process and release of drugs from the delivery system. 3.1 Definition of mucoadhesion: Mucoadhesion is defined as the adhesion between a mucoadhesive polymer and the mucosal surface. The mucoadhesive polymer may be a natural or synthetic substance that is capable of forming hydrogen bonds or other intermolecular forces with the mucin glycoproteins present on the mucosal surface (Mansuri et al., 2016). 3.2 Factors affecting mucoadhesion: Several factors can affect the mucoadhesive properties of a drug delivery system, including: Polymer properties: The molecular weight, charge, and hydrophilicity of the polymer can affect the mucoadhesive properties of the drug delivery system. Mucosal surface properties: The composition, hydration level, and surface roughness of the mucosal surface can affect the mucoadhesion process. pH: The pH of the drug delivery system and the mucosal surface can affect the mucoadhesion process. Drug properties: The solubility, molecular weight, and charge of the drug can affect the mucoadhesive properties of the drug delivery system (Madhavi et al., 2010). 3.3 Types of mucoadhesive polymers: There are several types of mucoadhesive polymers, including: ➢ Natural polymers: Examples of natural polymers include chitosan, alginate, hyaluronic acid, and carrageenan. ➢ Synthetic polymers: Examples of synthetic polymers include poly(acrylic acid), polyethylene glycol (PEG), and polyvinyl alcohol (PVA).
➢ Semi-synthetic polymers: Examples of semi-synthetic polymers include cellulose derivatives such as hydroxypropyl methylcellulose (HPMC) and methylcellulose (MC) (Peppas & Huang, 2004). 3.4 Mechanisms of mucoadhesion: The mechanism of mucoadhesion involves the following simple steps: Contact between mucoadhesive substance and mucosal surface: The first step is the contact between the mucoadhesive substance and the mucosal surface. Wetting and swelling: The mucoadhesive substance begins to wet and swell as it comes into contact with the mucosal surface. This allows it to penetrate into the mucus layer on the mucosal surface. Intermolecular forces: The mucoadhesive substance forms intermolecular forces with the mucus layer and the mucosal surface. These forces can include hydrogen bonding, electrostatic interactions, and van der Waals forces. Bond formation: The intermolecular forces lead to the formation of chemical bonds between the mucoadhesive substance and the mucosal surface. Adhesion strength: The strength of the adhesion is dependent on the number and strength of the chemical bonds formed. Rupture of bonds: When a force is applied to the adhesion site, the chemical bonds begin to rupture sequentially until the adhesion is broken. Figure 2 : Mechanisms of mucoadhesion (“Mucoadhesive Polymers and Their Mode of Action,” 2017).
surface. According to this theory, the mucoadhesive polymer adsorbs onto the mucosal surface and forms bonds with the surface, leading to strong adhesion. 4.3 Wetting theory : The wetting theory applies to liquid systems which present affinity to the surface in order to spread over it. This affinity can be measure by contact angle. The general rule states that the lower the contact angle then the greater the affinity. The contact angle should be equal or close to zero lo provide adequate spreadability.
4. 4 Diffusion theory: The diffusion theory of mucoadhesion suggests that adhesion occurs due to the diffusion of the mucoadhesive polymer into the mucus layer. The theory proposes that the polymer chains penetrate the mucus layer and form interpenetrating networks, leading to strong adhesion. 4.5 Fracture theory: The Fracture Theory of mucoadhesion is a concept that explains how a mucoadhesive substance sticks to a mucosal surface through the formation and sequential rupture of chemical bonds. This theory is used to develop mucoadhesive drug delivery systems that enhance drug absorption and retention at mucosal surfaces. 4.6 Mechanical theory: This theory consider adhesion to be due to the filling or the irregularities on a rough surface by a mucoadhesive liquid. Moreover, such roughness increases the interracial area available lo interactions thereby aiding dissipating energy and can be considered the most important phenomenon of the process (Smart, 2014). Figure 3 : Wetting Theory (Left) (Jiménez-Castellanos et al., 2008), Fracture Theory (Right) (Madhavi et al., 2010). Overall, the theories of mucoadhesion help to explain the mechanisms by which drug delivery systems can adhere to mucosal surfaces. Understanding these mechanisms can aid in the development of more effective mucoadhesive formulations for improved drug delivery.
Part- 2
5. Different Sites of Mucosal Drug Delivery Systems
Figure 4 : Different sites of mucosal drug delivery systems (Kumar et al., 2020). Mucosal surfaces are found in various sites in the body, including the oral cavity, buccal cavity, nasal passages, lungs, gastrointestinal tract, rectum, and vagina. Each of these sites presents unique challenges and opportunities for drug delivery. 5.1 Oral cavity drug delivery system The oral cavity drug delivery system is a type of mucosal drug delivery system that is designed to deliver drugs directly to the oral cavity mucosa. The oral cavity drug delivery system offers several advantages, including rapid onset of action, avoidance of first-pass metabolism in the liver, and reduced gastrointestinal side effects. There are various types of oral cavity drug delivery systems, including: ❖ Mouthwash and gargles: These are liquid formulations that are swished around the mouth and then spit out. They can be used for the local treatment of oral conditions, such as gum disease or thrush, or for systemic drug delivery. ❖ Sublingual tablets and films: These are solid formulations that are placed under the tongue and dissolve in the saliva. They can be used for the local treatment of oral conditions, such as cold sores or ulcers, or for systemic drug delivery.
including rapid onset of action, avoidance of first-pass metabolism in the liver, and reduced gastrointestinal side effects. There are various types of nasal drug delivery systems, including: Nasal sprays and drops: These are liquid formulations that are administered through the nostrils. They can be used for the local treatment of nasal conditions, such as allergies or sinusitis, or for systemic drug delivery. Nasal powders: These are dry powder formulations that are inhaled through the nostrils. They can be used for the local treatment of nasal conditions, such as allergies or nasal congestion, or for systemic drug delivery. The nasal drug delivery system can be used to treat a variety of conditions, including allergies, nasal congestion, and migraine headaches. It can also be used to deliver drugs systemically, such as for the treatment of pain or nausea. The choice of nasal drug delivery system will depend on the specific drug and therapeutic need, as well as the desired duration of action and rate of drug release (Jiménez-Castellanos et al., 2008). 5.4 Pulmonary drug delivery system The pulmonary drug delivery system is a type of mucosal drug delivery system that is designed to deliver drugs directly to the lungs. The pulmonary drug delivery system offers several advantages, including rapid onset of action, avoidance of first-pass metabolism in the liver, and reduced gastrointestinal side effects. There are various types of pulmonary drug delivery systems, including: Inhalers: These are handheld devices that deliver a metered dose of medication to the lungs. Inhalers can be used to treat a variety of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Nebulizers: These are devices that convert liquid medication into a mist that can be inhaled through a mouthpiece or mask. Nebulizers can be used to treat respiratory conditions that require higher doses of medication, such as cystic fibrosis. The pulmonary drug delivery system can be used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. It can also be used to deliver drugs systemically,
such as for the treatment of pulmonary hypertension or lung cancer. The choice of pulmonary drug delivery system will depend on the specific drug and therapeutic need, as well as the desired duration of action and rate of drug release (Kharenko et al., 2009). 5.5 Gastrointestinal drug delivery system The gastrointestinal drug delivery system is a type of mucosal drug delivery system that is designed to deliver drugs directly to the gastrointestinal tract. The gastrointestinal drug delivery system offers several advantages, including targeted delivery to the site of action, sustained release of drugs, and improved patient compliance. There are various types of gastrointestinal drug delivery systems, including: Tablets and capsules: These are solid formulations that are designed to release drugs at specific sites in the gastrointestinal tract. They can be used for the treatment of a variety of conditions, such as ulcers, inflammatory bowel disease, and colorectal cancer. Microspheres and nanoparticles: These are small particles that are designed to release drugs in a controlled manner over an extended period of time. They can be used for the treatment of chronic conditions, such as Crohn's disease and ulcerative colitis. Coated pellets: These are small, spherical pellets that are coated with a drug-containing layer. The coating can be designed to release the drug at different sites in the gastrointestinal tract, allowing for targeted delivery. The gastrointestinal drug delivery system can be used to treat a variety of conditions, including ulcers, inflammatory bowel disease, and colorectal cancer. It can also be used to deliver drugs systemically, such as for the treatment of hepatitis or diabetes. The choice of gastrointestinal drug delivery system will depend on the specific drug and therapeutic need, as well as the desired duration of action and rate of drug release (Jiménez-Castellanos et al., 2008). 5.6 Rectal drug delivery system The rectal drug delivery system is a type of mucosal drug delivery system that is designed to deliver drugs directly to the rectal mucosa. The rectal drug delivery system offers several advantages, including rapid onset of action, avoidance of first-pass metabolism in the liver, and reduced gastrointestinal side effects.
The vaginal drug delivery system can be used to treat a variety of conditions affecting the vaginal mucosa, including bacterial vaginosis, yeast infections, and menopausal symptoms. It can also be used for contraception and for the prevention of sexually transmitted infections. The choice of vaginal drug delivery system will depend on the specific drug and therapeutic need, as well as the desired duration of action and rate of drug release (Jiménez-Castellanos et al., 2008).
6. Advantages and Limitations of Mucosal Drug Delivery System
6.1 Advantages of mucosal drug delivery Mucosal drug delivery system offers several advantages over traditional drug delivery systems. Firstly, it provides faster onset of action due to direct drug delivery to the site of action. Secondly, it reduces the potential for systemic toxicity by minimizing drug exposure to other parts of the body. Thirdly, it offers improved bioavailability, as the drug bypasses first-pass metabolism in the liver. Fourthly, it offers improved patient compliance due to ease of administration and reduced frequency of dosing. Finally, it offers the potential for targeted drug delivery to specific sites in the body. Here are some advantages of mucosal drug delivery in pharmaceuticals: ❖ Rapid onset of action: Mucosal drug delivery offers faster absorption and onset of action than traditional oral drug delivery methods. This is due to the rich blood supply and large surface area of mucosal tissues. ❖ Avoidance of first-pass metabolism: Mucosal drug delivery bypasses the liver and the gastrointestinal tract, which can metabolize and degrade drugs before they reach their target site. This results in higher bioavailability and therapeutic efficacy. ❖ Reduced dosage and frequency: Mucosal drug delivery allows for lower dosages and less frequent administration of drugs, as they are directly delivered to the site of action. This can reduce the risk of adverse effects and improve patient compliance. ❖ Targeted drug delivery: Mucosal drug delivery can specifically target the affected tissues, organs or cells, which can reduce the risk of systemic side effects and improve therapeutic outcomes. ❖ Non-invasive route of administration: Mucosal drug delivery is a non-invasive and convenient route of administration, which can improve patient comfort and adherence to treatment.
❖ Improved stability and shelf life: Mucosal drug delivery can improve the stability and shelf life of drugs, as they are protected from enzymatic degradation and chemical instability. ❖ Versatility: Mucosal drug delivery can be applied to a wide range of drugs, including small molecules, peptides, proteins, vaccines and gene therapies. ❖ Reduced cost and time of drug development: Mucosal drug delivery can reduce the cost and time of drug development by improving drug efficacy, reducing side effects, and allowing for lower dosages and less frequent administration. Overall, mucosal drug delivery offers several advantages over traditional oral drug delivery methods, making it a promising approach in pharmaceuticals (Zhang et al., 2002). 6.2 Limitations of mucosal drug delivery Mucosal drug delivery systems offer several advantages over other routes of drug administration, but they also have some limitations. Here are some limitations of mucosal drug delivery systems: Limited drug compatibility: Mucosal drug delivery systems can be limited in their compatibility with certain drugs, which can limit their use for certain therapeutic applications. Mucosal irritation: Some mucosal drug delivery systems can cause mucosal irritation, which can limit their tolerability and use. Limited surface area: Mucosal surfaces have a limited surface area, which can limit the amount of drug that can be delivered through mucosal drug delivery systems. Difficulty in achieving sustained release: Achieving sustained release of drugs through mucosal drug delivery systems can be challenging due to the rapid clearance of drugs from mucosal surfaces. In summary, mucosal drug delivery systems offer several advantages over other routes of drug administration, but their use can be limited by drug compatibility, mucosal irritation, limited surface area, and difficulty in achieving sustained release. The choice of mucosal drug delivery system will depend on the specific drug and therapeutic need, as well as the desired duration of action and rate of drug release (Kumar et al., 2020).
8. Conclusion
In conclusion, mucosal drug delivery systems have emerged as a promising approach for improving the delivery of drugs in the pharmaceutical industry. These systems offer several advantages over traditional drug delivery systems, including enhanced bioavailability, targeted drug delivery, improved patient compliance, reduced dose variability, and faster onset of action. By bypassing the first-pass metabolism in the liver, mucosal drug delivery systems can improve drug absorption and increase bioavailability. They can also be designed to target specific tissues or organs in the body, which can improve drug efficacy while minimizing systemic side effects. Moreover, mucosal drug delivery systems can improve patient compliance and adherence to treatment by offering more convenient and less invasive drug administration methods. This is particularly important for patients with chronic conditions that require long-term treatment. Overall, the development and application of mucosal drug delivery systems in the pharmaceutical industry is a rapidly evolving field with tremendous potential for improving drug therapy outcomes. As such, ongoing research and development efforts are likely to result in the development of new and innovative mucosal drug delivery systems that can address a range of medical conditions and patient needs.
9. References
1 Alexander, A., Ajazuddin, Tripathi, D. K., Verma, T., Swarna, Maurya, J., & Patel, S. (2011). Mechanism responsible for mucoadhesion of mucoadhesive drug delivery system: A review. http://imsear.searo.who.int/handle/123456789/ 2 Berkowitz, A. C., & Goddard, D. M. (2009). Novel Drug Delivery Systems: Future Directions. Journal of Neuroscience Nursing, 41(2) , 115. https://doi.org/10.1097/JNN.0b013e318193458b 3 Cruchley, A. T., & Bergmeier, L. A. (2018). Structure and Functions of the Oral Mucosa. In L. A. Bergmeier (Ed.), Oral Mucosa in Health and Disease: A Concise Handbook (pp. 1–18). Springer International Publishing. https://doi.org/10.1007/978- 3 - 319 - 56065 - 6_ 4 Harris, D., & Robinson, J. R. (1992). Drug Delivery via the Mucous Membranes of the Oral Cavity. Journal of Pharmaceutical Sciences, 81(1) , 1 – 10. https://doi.org/10.1002/jps. 5 Jiménez-Castellanos, M., Zia, H., & Rhodes, C. (2008). Mucoadhesive Drug Delivery Systems. Drug Dev Ind Pharm, 19 , 143 – 194. https://doi.org/10.3109/ 6 Kharenko, E. A., Larionova, N. I., & Demina, N. B. (2009). Mucoadhesive drug delivery systems (Review). Pharmaceutical Chemistry Journal, 43(4) , 200 – 208. https://doi.org/10.1007/s11094- 009 - 0271 - 6 7 Kumar, A., Naik, P. K., Pradhan, D., Ghosh, G., & Rath, G. (2020). Mucoadhesive formulations: Innovations, merits, drawbacks, and future outlook. Pharmaceutical Development and Technology, 25(7) , 797 – 814. https://doi.org/10.1080/10837450.2020. 8 Laffleur, F., & Bernkop-Schnürch, A. (2013). Strategies for improving mucosal drug delivery. Nanomedicine, 8(12) , 2061–2075. https://doi.org/10.2217/nnm.13. 9 Madhavi, B., Mohammed, Z., Anisetti, R. N., & Banji, D. (2010). Mucoadhesive drug delivery system: An overview. Journal of Advanced Pharmaceutical Technology & Research, 1 , 381–387. https://doi.org/10.4103/0110-5558.
